Fulcrum Therapeutics News

Fulcrum Therapeutics | EFFECT: Others

Apr 26 05:09

Fulcrum Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 8 17:02

Fulcrum Therapeutics | 424B5: Prospectus

Jan 18, 2023 16:08

Fulcrum Therapeutics | 424B5: Prospectus

Jan 17, 2023 16:26

Fulcrum Therapeutics | 424B5: Prospectus

Aug 16, 2022 16:55

Fulcrum Therapeutics | 424B5: Prospectus

Aug 15, 2022 17:14

Fulcrum Therapeutics | 424B5: Prospectus

May 9, 2022 20:54

Fulcrum Therapeutics | EFFECT: Others

Apr 28, 2022 23:15

Fulcrum Therapeutics | 424B5: Prospectus

Aug 12, 2021 15:38

Fulcrum Therapeutics | 424B5: Prospectus

Aug 10, 2021 18:55

Fulcrum Therapeutics | 424B5: Prospectus

Jan 20, 2021 15:02

Fulcrum Therapeutics | 424B5: Prospectus

Jan 19, 2021 15:12

Fulcrum Therapeutics | EFFECT: Others

Aug 17, 2020 23:15

Fulcrum Therapeutics | EFFECT: Others

Aug 12, 2020 23:15

Fulcrum Therapeutics | EFFECT: Others

Jul 7, 2020 23:16

Fulcrum Therapeutics | 424B4: Prospectus

Jul 18, 2019 16:19

Fulcrum Therapeutics | EFFECT: Others

Jul 17, 2019 23:15

Fulcrum Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jul 12, 2019 16:21